In the 100 years since TURP was invented, surgical retreatment has meant one thing: a BPH treatment performed a second time. In many of today’s clinical studies for BPH, surgical retreatment rate points to study subjects who undergo repeat surgical treatment during the duration of a clinical study.
From August 22nd through the 25th, in Whitefish, Montana, Advances in Men’s Health hosted their first ever men’s health conference. Participants at this conference were provided relevant and innovative men’s healthcare education to both primary care and urology providers. This conference also featured presentations from industry leaders, like Summit Urology Group’s very own Dr. Steven N. Gange. Dr. Steven N. Gange also served as the program director and is available to answer any questions you may have about upcoming men’s health conferences.
For more information, contact our office at (801) 993-1800 today!
Steven N. Gange, MD, FACS, Director of Research and Education at Granger Medical Clinic/Summit Urology Group, conducted a propensity score-matched study comparing Focal Therapy vs. Radical Prostatectomy. Focal therapy is a non-invasive approach to removing small tumors within the prostate. This technique spares most of the normal tissue while leaving the remaining gland intact. Radical Prostatectomy is the classic way of removing the prostate which includes removing the prostate gland and the surrounding tissue. Until now, a propensity score-matched study comparing focal therapy (FT) for localized prostate cancer to radical prostatectomy (RP) has never been reported.
Dr. Steven Gange was recently featured in an article about the new UroLift® Advanced Tissue Control (ATC)™ System.
Dr. Gange, urologist in Salt Lake City, UT., thanks NeoTract for making it possible to be able to offer a service which transforms the lives of BPH patients. He expects there will be a great demand in The Urolift System after these times are over.
Teleflex has announced that 175,000 Patients Treated with the UroLift® System, a minimally invasive approach that provides rapid relief and recovery of BPH symptoms.
Dr. Gange and Summit Urology Group is closely following the most up-to-date announcements and information on the known cases of Novel Coronavirus (COVID-19). Because this information is always changing, we will be monitoring all updated from the World Health Organization and Centers for Disease Control.
If you are experiencing cold or flu symptoms, please make sure to contact us via phone prior to your appointment. You may also contact us for any additional questions by calling our office at (801) 993-1800.
Here are a few additional resources as well:
World Health Organization
Centers for Disease Control
Free HIFU Informational Seminar with Dr. Steven Gange
Prostate cancer is one of the common forms of cancer in men and, if caught in its early stages, can be treated and cured. High Intensity Focused Ultrasound (HIFU) treatment is most effective for men who have localized prostate cancer in its early stages. If you are weighing your options and would like more information, join Summit Urology Group and Dr. Steven Gange for a free informational seminar to learn more about HIFU treatment and find out if it is right for you.
- Date: Tuesday October 1
- Time: 6:00 PM
- Location: 4252 South Highland Dr. Salt Lake City
Dr. Gange is here to help you find a treatment option that is best for you and wants to help you on your road through treatment and recovery. For more information on this seminar, call Dr. Gange’s office at (801) 993-1800.
Dr. Steven Gange is going to be interviewed on Doctor Radio this Wednesday from 7-8 PM Eastern. He will be discussing several topics as they relate to BPH including symptoms, treatment options, new research, and more.
Now Available with Steven Gange, MD in Utah
HIFU, or High Intensity Focused Ultrasound, is a minimally invasive, outpatient treatment for prostate cancer
CHARLOTTE, N.C. August 1, 2019 – HIFU Prostate Services, LLC has partnered with Steven Ganage, MD to offer HIFU in Salt Lake City, UT. Learn more here!, the leading provider of HIFU technology to physician practices in the United States, has partnered with Steven Gange, MD to make HIFU available in the greater Salt Lake City area.
The first patients in Utah were treated by Dr. Gange this week at Lone Peak Surgery Center and Canyon Crest Surgery Center.
Dr. Gange first learned about HIFU and started treating patients outside the U.S. in 2007. He was impressed with the technology from early on and wanted to be able to offer it to patients locally as soon as he could.
“I immediately appreciated the remarkable science of HIFU, and its minimally invasive nature fit into my existing general approach to urological care. When I began seeing the cancer outcomes and lack of significant side effects, I was even more impressed,” said Dr. Gange.
HIFU is administered through a transrectal probe that focuses ultrasound energy to the prostate to rapidly heat and destroy tissue. Due to the nature of ultrasound energy and the accuracy of HIFU, areas outside the targeted tissue are undamaged which greatly reduces the risk of side effects such as urinary incontinence and erectile dysfunction.
“HIFU offers effective cancer control with minimal sexual and urinary risk. It is truly precise delivery of cancer cell ablative energy,” Dr. Gange said.
HIFU may also be an acceptable salvage treatment if men have already had radiation and their prostate cancer has returned. Although it is typically a one-time therapy, HIFU may be repeated if necessary and does not preclude any future treatments including surgery or radiation.
”We are excited to be working with Dr. Gange in Salt Lake City. He is a pioneer in urology and is always looking for the optimal treatment for the patient that minimizes any impact to quality of life”, commented John Linn, CEO of HIFU Prostate Services.
In an effort to further educate his community about HIFU and non-invasive prostate cancer treatment options, Dr Gange will be holding a FREE Seminar to discuss HIFU or Men’s Prostate Health on Tuesday, October 1 at 6:00 PM at his Summit Urology Group office located at 4252 South Highland Drive, Suite 200 in Salt Lake City, Utah. Dr Gange invites prostate cancer patients, their loved ones, or anyone wishing to learn more about prostate health or HIFU as a treatment option for prostate cancer. Guests are welcome, but please confirm as seating is limited. Attendees are asked to call (844) 749-9021 to RSVP.
About HIFU Prostate Services, LLC
HIFU Prostate Services was founded to provide men access to a less invasive treatment option for prostate cancer that has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and with locations in 24 cities throughout the US. Learn more at http://www.hifuprostateservices.com.
John Linn, 877-884-4432
HIFU Prostate Services